SAN DIEGO & SINGAPORE, Oct 20 (Bernama-BUSINESS WIRE) — ImmunoScape, a biotechnology company focused on next-generation immunotherapies, published new peer-reviewed research that demonstrates the use of machine learning to predict the virus specificity of human T-cells. The research, led by ImmunoScape Scientist Michael Fehlings, Ph.D., was published in the scientific journal, Cell Reports. The research could have profound implications for the use of machine learning in the discovery and development of T-cell based immunotherapies.
The Study